Preprint · 2025
Cancer immunotherapy offers a promising long-term treatment for solid tumors by activating the immune system, but side effects and systemic toxicity limit its broad clinical translation. While intratumoral delivery addresses these limitations, elevated sti ...
Full textCite
https://orcid.org/0000-0002-4872-6711